3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake

3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Beadle, Christopher David, Cases-Thomas, Manuel Javier, Clark, Barry Peter, Gallagher, Peter Thaddeus, Masters, John Joseph, Timms, Graham Henry, Walter, Magnus Wilhelm, Whatton, Maria Ann, Wood, Virginia Ann, Gilmore, Jeremy
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Beadle, Christopher David
Cases-Thomas, Manuel Javier
Clark, Barry Peter
Gallagher, Peter Thaddeus
Masters, John Joseph
Timms, Graham Henry
Walter, Magnus Wilhelm
Whatton, Maria Ann
Wood, Virginia Ann
Gilmore, Jeremy
description The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07432280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07432280</sourcerecordid><originalsourceid>FETCH-uspatents_grants_074322803</originalsourceid><addsrcrecordid>eNrjZPA11k3MzczLL8gsSC3KTMnMSy1WSMxLUYAKF5Zm5pUm58AkihUy8zIykzJL8ouKFfLTFHLz8_JB6lIVSgtKErNTeRhY0xJzilN5oTQ3g4Kba4izh25pcUFiSWpeSXF8elEiiDIwNzE2MrIwMCZCCQC2Gzdb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake</title><source>USPTO Issued Patents</source><creator>Beadle, Christopher David ; Cases-Thomas, Manuel Javier ; Clark, Barry Peter ; Gallagher, Peter Thaddeus ; Masters, John Joseph ; Timms, Graham Henry ; Walter, Magnus Wilhelm ; Whatton, Maria Ann ; Wood, Virginia Ann ; Gilmore, Jeremy</creator><creatorcontrib>Beadle, Christopher David ; Cases-Thomas, Manuel Javier ; Clark, Barry Peter ; Gallagher, Peter Thaddeus ; Masters, John Joseph ; Timms, Graham Henry ; Walter, Magnus Wilhelm ; Whatton, Maria Ann ; Wood, Virginia Ann ; Gilmore, Jeremy ; Eli Lilly and Company</creatorcontrib><description>The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7432280$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7432280$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Beadle, Christopher David</creatorcontrib><creatorcontrib>Cases-Thomas, Manuel Javier</creatorcontrib><creatorcontrib>Clark, Barry Peter</creatorcontrib><creatorcontrib>Gallagher, Peter Thaddeus</creatorcontrib><creatorcontrib>Masters, John Joseph</creatorcontrib><creatorcontrib>Timms, Graham Henry</creatorcontrib><creatorcontrib>Walter, Magnus Wilhelm</creatorcontrib><creatorcontrib>Whatton, Maria Ann</creatorcontrib><creatorcontrib>Wood, Virginia Ann</creatorcontrib><creatorcontrib>Gilmore, Jeremy</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><title>3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake</title><description>The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZPA11k3MzczLL8gsSC3KTMnMSy1WSMxLUYAKF5Zm5pUm58AkihUy8zIykzJL8ouKFfLTFHLz8_JB6lIVSgtKErNTeRhY0xJzilN5oTQ3g4Kba4izh25pcUFiSWpeSXF8elEiiDIwNzE2MrIwMCZCCQC2Gzdb</recordid><startdate>20081007</startdate><enddate>20081007</enddate><creator>Beadle, Christopher David</creator><creator>Cases-Thomas, Manuel Javier</creator><creator>Clark, Barry Peter</creator><creator>Gallagher, Peter Thaddeus</creator><creator>Masters, John Joseph</creator><creator>Timms, Graham Henry</creator><creator>Walter, Magnus Wilhelm</creator><creator>Whatton, Maria Ann</creator><creator>Wood, Virginia Ann</creator><creator>Gilmore, Jeremy</creator><scope>EFH</scope></search><sort><creationdate>20081007</creationdate><title>3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake</title><author>Beadle, Christopher David ; Cases-Thomas, Manuel Javier ; Clark, Barry Peter ; Gallagher, Peter Thaddeus ; Masters, John Joseph ; Timms, Graham Henry ; Walter, Magnus Wilhelm ; Whatton, Maria Ann ; Wood, Virginia Ann ; Gilmore, Jeremy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_074322803</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Beadle, Christopher David</creatorcontrib><creatorcontrib>Cases-Thomas, Manuel Javier</creatorcontrib><creatorcontrib>Clark, Barry Peter</creatorcontrib><creatorcontrib>Gallagher, Peter Thaddeus</creatorcontrib><creatorcontrib>Masters, John Joseph</creatorcontrib><creatorcontrib>Timms, Graham Henry</creatorcontrib><creatorcontrib>Walter, Magnus Wilhelm</creatorcontrib><creatorcontrib>Whatton, Maria Ann</creatorcontrib><creatorcontrib>Wood, Virginia Ann</creatorcontrib><creatorcontrib>Gilmore, Jeremy</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Beadle, Christopher David</au><au>Cases-Thomas, Manuel Javier</au><au>Clark, Barry Peter</au><au>Gallagher, Peter Thaddeus</au><au>Masters, John Joseph</au><au>Timms, Graham Henry</au><au>Walter, Magnus Wilhelm</au><au>Whatton, Maria Ann</au><au>Wood, Virginia Ann</au><au>Gilmore, Jeremy</au><aucorp>Eli Lilly and Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake</title><date>2008-10-07</date><risdate>2008</risdate><abstract>The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07432280
source USPTO Issued Patents
title 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T00%3A49%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Beadle,%20Christopher%20David&rft.aucorp=Eli%20Lilly%20and%20Company&rft.date=2008-10-07&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07432280%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true